Țară: Regatul Unit
Limbă: engleză
Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)
Folic acid
Dalkeith Laboratories Ltd
B03BB01
Folic acid
5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010200; GTIN: 5039290001072
Package leaflet: Information for the user FOLIC ACID TABLETS BP 5 MG This medicine will be called Folic Acid Tablets in this leaflet. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Folic Acid Tablets are and what they are used for 2. What you need to know before you take Folic Acid Tablets 3. How to take Folic Acid Tablets 4. Possible side effects 5. How to store Folic Acid Tablets 6. Contents of the pack and other information 1. What Folic Acid Tablets are and what they are used for Folic acid belongs to the Vitamin B group. It is necessary for the normal production of blood cells. Folic Acid Tablets may be used: To treat: • Folate deficiency anaemia caused by poor diet, poor absorption of food (such as in coeliac disease or a digestive disorder called sprue) or increased use of folate in the body (as in pregnancy) To prevent: • Folate deficiency caused by some medicines (e.g. those used to treat epilepsy such as phenytoin, phenobarbital and primidone) • Folate deficiency caused by long-term red blood cell damage or kidney dialysis • Neural tube defects in babies (e.g. spina bifida), where women are at risk of having an affected child. 2. What you need to know before you take Folic Acid Tablets Do not take Folic Acid Tablets if: • You are allergic to folic acid or to any of the other ingredients of this medicine (listed in section 6) • You have an untreated vitamin B12 deficiency such as in certain anaemias and lifelong vegetarians • You are suffering from pe Citiți documentul complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Folic Acid Tablets BP 5 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Folic Acid hydrate 5 mg Excipients with known effect 50.4 mg lactose & 2.8 mg sucrose per tablet For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablets Plain yellow, round uncoated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Folic acid is a component of the B group of vitamins and is necessary for the normal production and maturation of blood cells. For the treatment of folate-deficient megaloblastic anaemia due to malnutrition, malabsorption syndromes (such as coeliac disease or sprue) and increased utilisation as in pregnancy. It should not be used alone in undiagnosed megaloblastic anaemia including in infancy, pernicious anaemia or macrocytic anaemia of unknown aetiology, unless administered with adequate amounts of hydroxocobalamin. For the prophylaxis of drug induced folate deficiency e.g. caused by administration of phenytoin, phenobarbital and primidone. (See section 4.5). For the prophylaxis against folate deficiency in chronic haemolytic states or in renal dialysis. For the prevention of neural tube defects for woman planning a pregnancy and known to be at risk. (See section 4.6). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology ADULTS (INCLUDING THE ELDERLY) _In folate deficient megaloblastic anaemia_: 5mg daily for 4 months; up to 15mg daily may be necessary for malabsorption states. _ _ _In drug induced folate deficiency: _5mg daily for 4 months; up to 15mg daily may be necessary for malabsorption states. _ _ _For prophylaxis in chronic haemolytic states or in renal dialysis: _5mg every 1-7 days depending on underlying disease. _ _ _Prevention of neural tube defects in women known to be at risk_: 5mg daily started before conception and continued throughout the first trimester. Pregnancy: _In established folate deficiency: _5mg daily continued to term. _ _ PAEDIATRIC POPULATION For young children a more Citiți documentul complet